Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study

M. Attauabi, J. F. Dahlerup, A. Poulsen, M. Rosager Hansen, M. K. Vester-Andersen, S. Eraslan, A. P. Prahm, N. Pedersen, L. Larsen, T. Jess, A. Neumann, K. V. Haderslev, A. Molazahi, A. B. Lødrup, H. Glerup, A. M. Oppfeldt, M. D. Jensen, K. Theede, M. Kiszka-Kanowitz, J. B. SeidelinJ. Burisch, the Danish COVID-IBD Study Group

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftJournal of Crohn's & colitis
Vol/bind16
Udgave nummerSuppl. 1
Sider (fra-til)I587-I588
ISSN1873-9946
DOI
StatusUdgivet - jan. 2022
Begivenhed17th Congress of ECCO - Virtual
Varighed: 16 feb. 202219 feb. 2022
Konferencens nummer: 17

Konference

Konference17th Congress of ECCO
Nummer17
LokationVirtual
Periode16/02/202219/02/2022

Bibliografisk note

Abstrakt No. P686

Citationsformater